At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.

Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.

Find out more about:

Bill Walsh Translational Cancer Research Laboratory

Bowel Cancer and Biomarker Research Lab

Breast Cancer Research

Cancer Genetics Laboratory

Kolling Institute Tumour Bank

Events, News and Seminars

The Kolling’s up and coming talent recognised

The Kolling’s up and coming talent recognised

Acting Executive Director Professor Jim Elliott has announced the winners of the inaugural Kolling I..... Read more

Category: Awards

First Australian imaging technology to deliver research windfall

First Australian imaging technology to deliver research windfall

An exciting project between the University of Sydney and the Northern Sydney Local Health District ..... Read more

Category: World-leading technology

Cancer expertise recognised

Cancer expertise recognised

The Kolling’s Dr Amanda Hudson will lead an exciting pilot study after being awarded an innovation g..... Read more

Category: Funding support, Neuroscience and Pain Research